U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H24N4O2
Molecular Weight 424.4944
Optical Activity NONE
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Pifusertib

SMILES

C[C@@]1(O)C[C@@](N)(C1)C2=CC=C(C=C2)C3=C(N4COC5=C(C=NC=C5)C4=N3)C6=CC=CC=C6

InChI

InChIKey=AIFGVDXMHWGOGJ-DIVCQZSQSA-N
InChI=1S/C26H24N4O2/c1-25(31)14-26(27,15-25)19-9-7-17(8-10-19)22-23(18-5-3-2-4-6-18)30-16-32-21-11-12-28-13-20(21)24(30)29-22/h2-13,31H,14-16,27H2,1H3/t25-,26-

HIDE SMILES / InChI

Molecular Formula C26H24N4O2
Molecular Weight 424.4944
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:59:13 GMT 2023
Edited
by admin
on Sat Dec 16 14:59:13 GMT 2023
Record UNII
QI52W1ZIIB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Pifusertib
INN  
Official Name English
TAS 117 [WHO-DD]
Common Name English
(1r,3r)-3-amino-1-methyl-3-[4-(3-phenyl-5Himidazo[1,2-c]pyrido[3,4-e][1,3]oxazin-2-yl)phenyl]cyclobutan-1-ol
Systematic Name English
TAS-117
Common Name English
TAS 117
Code English
TRANS-3-AMINO-1-METHYL-3-(4-(3-PHENYL-5H-IMIDAZO(1,2-C)PYRIDO(3,4-E)(1,3)OXAZIN-2-YL)PHENYL)CYCLOBUTANOL
Systematic Name English
pifusertib [INN]
Common Name English
Cyclobutanol, 3-amino-1-methyl-3-[4-(3-phenyl-5H-imidazo[1,2-c]pyrido[3,4-e][1,3]oxazin-2-yl)phenyl]-, trans-
Systematic Name English
Code System Code Type Description
DRUG BANK
DB15054
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
SMS_ID
300000026356
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
FDA UNII
QI52W1ZIIB
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
NCI_THESAURUS
C178300
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
CAS
1402602-94-1
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
INN
12291
Created by admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
ALLOSTERIC INHIBITOR
IC50
TARGET -> INHIBITOR
ALLOSTERIC INHIBITOR
IC50
TARGET -> INHIBITOR
ALLOSTERIC INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY
Originator: Taiho Pharmaceutical; Class: Antineoplastic; Mechanism of Action: Proto oncogene protein c-akt inhibitor; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes; Highest Development Phase: Phase I for Solid tumours; Most Recent Event: 01 Feb 2015 Phase-I clinical trials in Solid tumours (Late-stage disease, Metastatic disease) in Japan (PO)(JapicCTI152780)